South State Corp Penumbra Inc Transaction History

South State Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$151.88 - $228.5 $6,986 - $10,511	-46 Reduced 70.77%	19 $4,000
Q3 2022 Nov 07, 2022	SELL	$120.36 - $205.88 $8,545 - $14,617	-71 Reduced 52.21%	65 $12,000
Q4 2021 Feb 11, 2022	SELL	$238.08 - $288.0 $2,142 - $2,592	-9 Reduced 6.21%	136 $39,000
Q3 2021 Nov 10, 2021	SELL	$250.72 - $291.24 $13,789 - $16,018	-55 Reduced 27.5%	145 $39,000
Q3 2020 Nov 10, 2020	BUY	$185.27 - $238.73 $37,054 - $47,746	200 New	200 $39,000

409

29.2M

254K

43.3K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.3B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

Stay updated on South State Corp with notifications on news.